Cargando…

Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer

Epithelial ovarian cancer (EOC) is a significant cause of cancer-related mortality in women, and there has been no substantial decrease in the death rates due to EOC in the last three decades. Thus, basic knowledge regarding ovarian tumor cell biology is urgently needed to allow the development of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavoué, Vincent, Thédrez, Aurélie, Levêque, Jean, Foucher, Fabrice, Henno, Sébastien, Jauffret, Vincent, Belaud-Rotureau, Marc-Antoine, Catros, Veronique, Cabillic, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683338/ https://www.ncbi.nlm.nih.gov/pubmed/23763830 http://dx.doi.org/10.1186/1479-5876-11-147

Ejemplares similares

A Quantitative Deficiency in Peripheral Blood Vγ9Vδ2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients
por: Thedrez, Aurélie, et al.
Publicado: (2013)

The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer
por: Dion, Ludivine, et al.
Publicado: (2020)

Are preoperative histology and MRI useful for classification of endometrial cancer risk?
por: Body, Noemie, et al.
Publicado: (2016)

Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment
por: Parker, David, et al.
Publicado: (2014)

Array-CGH diagnosis in ovarian failure: identification of new molecular actors for ovarian physiology
por: Jaillard, Sylvie, et al.
Publicado: (2016)

Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations
por: Dugay, Frédéric, et al.
Publicado: (2017)

Ovarian Cancer: Latest Advances and Prospects
por: Dion, Ludivine, et al.
Publicado: (2021)

Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
por: Dabi, Yohann, et al.
Publicado: (2020)

Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma
por: Boisselier, Blandine, et al.
Publicado: (2018)

Tumor analysis: freeze–thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cells
por: Le Gallo, Matthieu, et al.
Publicado: (2018)

FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients
por: Hagedorn, Martin, et al.
Publicado: (2007)

Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
por: Kammerer-Jacquet, Solène-Florence, et al.
Publicado: (2019)

Functional Assessment of a New PBX1 Variant in a 46,XY Fetus with Severe Syndromic Difference of Sexual Development through CRISPR-Cas9 Gene Editing
por: Mary, Laura, et al.
Publicado: (2023)

Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases
por: Barbarin, Alice, et al.
Publicado: (2017)

Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
por: Malecki, Marek, et al.
Publicado: (2016)

Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency
por: Tucker, Elena J., et al.
Publicado: (2022)

The Epithelial-Immune Crosstalk in Pulmonary Fibrosis
por: Planté-Bordeneuve, Thomas, et al.
Publicado: (2021)

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO
por: Bengrine, Leila, et al.
Publicado: (2022)

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints
por: Hudry, Delphine, et al.
Publicado: (2022)

Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells
por: Daniel, Yoann, et al.
Publicado: (2021)

A novel immune-related prognostic signature in epithelial ovarian carcinoma
por: Su, Tong, et al.
Publicado: (2021)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Immunotherapy in Renal Cell Carcinoma: The Future Is Now
por: Deleuze, Antoine, et al.
Publicado: (2020)

Ovarian cancer in the older patient: where are we now? What to do next?
por: Rousseau, Frédérique, et al.
Publicado: (2023)

Book Review: The New Paradigm of Immunity to Tuberculosis
por: Ellis, Shawn D. P., et al.
Publicado: (2013)

Uterine Immunity and Microbiota: A Shifting Paradigm
por: Agostinis, Chiara, et al.
Publicado: (2019)

Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer
por: Kumar, Pavan, et al.
Publicado: (2023)

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment
por: Zhu, Ying, et al.
Publicado: (2020)

Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma
por: Verhoest, Grégory, et al.
Publicado: (2014)

Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer
por: Daudi, Sayeema, et al.
Publicado: (2014)

High Immune Expression of Progesterone-Induced Blocking Factor in Epithelial Ovarian Cancer
por: Madendag, Yusuf, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
por: Borella, Fulvio, et al.
Publicado: (2020)

Benefits of Minimal Access Surgery in Elderly Patients with Pelvic Cancer
por: Lavoué, Vincent, et al.
Publicado: (2016)

A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
por: Métairie, Marie, et al.
Publicado: (2023)

Ly49 Receptors: Innate and Adaptive Immune Paradigms
por: Rahim, Mir Munir A., et al.
Publicado: (2014)

Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms
por: Nicklas, J. Matthew, et al.
Publicado: (2020)

A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
por: Spranger, Stefani, et al.
Publicado: (2015)

Emerging paradigms in sepsis
por: Vincent, Jean-Louis
Publicado: (2022)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

Landscape of Immune Microenvironment in Epithelial Ovarian Cancer and Establishing Risk Model by Machine Learning
por: Liu, Shi-yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f2fl0pjbrm2kfssoe2otpij2kq